News from AMRI, Ark, and IMC – People on the move
Outsourcing-Pharma.com presents its latest round-up of the latest newcomers and career climbers in the world of pharmaceuticals, including news from AMRI, Ark, and IMC.
Archives for July 11, 2012
Acquisitions and contracts in Outsourcing-pharma.com's CMO news roundup
Ampac gets the OK from the DEA, Syngene lands PE-ED manufacturing contract and Great Southern is bought by Pernix Therapeutics – welcome to Outsourcing-pharma.com’s CMO round-up.
ICH move corrects regulator - industry power balance; expert
ICH has countered claims that industry influence is detrimental by cutting commercial interests' power over regulators, a consultant said.
Lonza says new platform cuts 6 weeks off cell line development
Lonza has launched a new version of its gene expression system that cuts weeks off the cell line development and construction process.
Dishman abandons pharma SEZ plan
Dishman Pharmaceuticals has abandoned plans to set up a special economic zone (SEZ) citing law changes that make the project less attractive and unfavourable economics as the reasons for the decision.
InVentiv further expands biz with patient counseling partnership
inVentiv Health’s medical management business – iMM – has partnered with patient behavioural counselling firm Vital Decisions to develop a care management and counselling programme for patients suffering from progressive disorders.